Moreover, survival analysis revealed HCC patients with high expression of CDX2 (DNA-binding transcription factor activity and transcription corepressor activity) or CHGA (autocrine or paracrine negative modulators of the neuroendocrine system) had lower survial proability (Figure 9D). Here, CDX2 is linked to hepatocellular carcinoma.